Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Vaestra Goetalandsregionen
Sponsor

Vaestra Goetalandsregionen

Sweden Regionens Hus, 462 80 Vänersborg, Sweden

About the sponsor

Research activity spans pancreatic cancer, glioblastoma, non-small cell lung cancer, multiple myeloma, breast cancer, and a broad range of melanoma subtypes, including uveal melanoma with liver metastases and in-transit metastasis. The portfolio also includes acute myeloid leukemia in both adult and pediatric settings, along with pediatric cancer and biomarker-oriented targeted cancer treatment.

  • Pancreatic adenocarcinoma
  • Melanoma and uveal melanoma
  • Glioblastoma
  • Acute myeloid leukemia
  • Multiple myeloma

Additional interest extends to somatostatin receptor positive tumours, metastatic disease, and surgical oncology contexts linked to hepatic resection and liver metastases.

About Specializations

Vaestra Goetalandsregionen runs clinical trials in conditions such as Pancreatic carcinoma, Acute myeloid leukaemia, Acute myocardial infarction, Coronary artery disease, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

41 clinical trials

Rheumatoid arthritis+1

Recruiting

A study to compare the effectiveness of rituximab and a placebo in patients with interstitial lung disease associated with rheumatoid arthritis

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Vaestra Goetalandsregionen

Therapy cessation

Recruiting

Study of the effects of stopping elranatamab and teclistamab treatment in patients with multiple myeloma who have had a significant response to therapy.

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Elranatamab
  • Sponsor:Vaestra Goetalandsregionen

Tick-borne encephalitis immunisation

Recruiting

Study on Tick-Borne Encephalitis: Evaluating T-Cell Responses Using Cytokine Release Assay in Healthy and Immunosuppressed Patients with TBE Vaccines

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Tick-borne encephalitis virus neudoerfl strain adsorbed on aluminium hydroxide, hydrated produced in chick embryo cells
  • Sponsor:Vaestra Goetalandsregionen

Measles

Recruiting

Study on Immunity to Measles and Chickenpox in Children with Cancer Using Measles, Mumps, Rubella, and Varicella Vaccines

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · Healthy volunteers
  • Substances:Measles virus edmonston-schwarz strain (live, attenuated) produced in chick embryo cells
  • Sponsor:Vaestra Goetalandsregionen

Pancreatic carcinoma

Recruiting

Study of Digitoxin with Chemotherapy for Patients with Inoperable Pancreatic Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Digitoxin
  • Sponsor:Vaestra Goetalandsregionen

Allogenic stem cell transplantation

Recruiting

Study on HPV Vaccine Timing for Patients After Stem Cell Transplantation Using Gardasil 9

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Human papillomavirus type 11 L1 protein
  • Sponsor:Vaestra Goetalandsregionen

Diabetic foot

Recruiting

Study on Sodium Hypochlorite and Polyhexamethylene Biguanide for Healing Diabetic Foot Ulcers in Patients with Diabetes

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Hypochlorite
  • Sponsor:University Of Gothenburg

Acute myeloid leukaemia

Recruiting

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Daunorubicin, Mitoxantrone, and a Drug Combination

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Cytarabine
  • Sponsor:Vaestra Goetalandsregionen

Procedural pain+2

Recruiting

Study on Pain Relief After Obesity Surgery Using Esketamine, Dexmedetomidine, and Lidocaine Hydrochloride Monohydrate for Patients Undergoing Obesity Surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dexmedetomidine
  • Sponsor:Vaestra Goetalandsregionen

Malignant melanoma

Recruiting

Study on the Effect of Nivolumab and Melphalan in Patients with In-Transit Melanoma Metastases

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Vaestra Goetalandsregionen

Osteoarthritis

Recruiting

Study Comparing Corticosteroid Injection and Arthrocentesis for Temporomandibular Joint Arthritis in Patients Using Methylprednisolone Acetate and Lidocaine Hydrochloride

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Vaestra Goetalandsregionen

Glioblastoma

Recruiting

Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Region Oestergoetland

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.